BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12594646)

  • 1. Key issues for a potential human immunodeficiency virus vaccine.
    Hu DJ; Vitek CR; Bartholow B; Mastro TD
    Clin Infect Dis; 2003 Mar; 36(5):638-44. PubMed ID: 12594646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An HIV vaccine: how and when?
    Esparza J
    Bull World Health Organ; 2001; 79(12):1133-7. PubMed ID: 11799445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public health considerations for the use of a first generation HIV vaccine. Report from a WHO-UNAIDS-CDC consultation, Geneva, 20-21 November 2002.
    Chang ML; Vitek C; Esparza J;
    AIDS; 2003 Oct; 17(15):W1-10. PubMed ID: 14523295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of vaccine research and development: the human immunodeficiency virus (HIV).
    Girard MP; Osmanov SK; Kieny MP
    Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials.
    Gilbert PB; DeGruttola VG; Hudgens MG; Self SG; Hammer SM; Corey L
    J Infect Dis; 2003 Jul; 188(2):179-93. PubMed ID: 12854072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS vaccine: efficacy, safety and ethics.
    Veljkovic V; Veljkovic N; Glisic S; Ho MW
    Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons for AIDS vaccine development from non-AIDS vaccines.
    Clements-Mann ML
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S197-203. PubMed ID: 9814944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenges of HIV vaccine development and testing.
    Burgers WA; Williamson C
    Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):277-91. PubMed ID: 15778116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [AIDS vaccines: promises and reality].
    Goudsmit J
    Ned Tijdschr Geneeskd; 2001 Jun; 145(26):1241-5. PubMed ID: 11455689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA.
    WHO/UNAIDS/IAVI International Expert Group
    AIDS; 2007 Feb; 21(4):539-46. PubMed ID: 17301582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS vaccine development: the long and winding road.
    Garber DA; Feinberg MB
    AIDS Rev; 2003; 5(3):131-9. PubMed ID: 14598562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental factors in HIV/AIDS epidemic development: new perspectives for gender equity and global protection against HIV transmission.
    Alfsen A
    Ann N Y Acad Sci; 2004 Jun; 1023():164-74. PubMed ID: 15253905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV vaccines under study.
    Ravanfar P; Mendoza N; Satyaprakash A; Jordan BI
    Dermatol Ther; 2009; 22(2):158-67. PubMed ID: 19335727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A safe, effective and affordable HIV vaccine--an urgent global need.
    Joseph J; Etcheverry F; Alcami J; MarĂ­a GJ
    AIDS Rev; 2005; 7(3):131-8. PubMed ID: 16302460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of primate models for AIDS.
    Haigwood NL
    AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaccines against HIV].
    Holm-Hansen C
    Tidsskr Nor Laegeforen; 2006 Nov; 126(23):3117-20. PubMed ID: 17160118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. World Bank works to develop an affordable, effective HIV vaccine.
    AIDS Wkly Plus; 1999 Sep; ():10-1. PubMed ID: 12319724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The elusive HIV vaccine: an update on the politics, propaganda and scientific barriers in the search for a safe and effective HIV vaccine.
    Allen D
    Posit Aware; 1999; 10(4):30-4, 37. PubMed ID: 11366804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV risk and prevention in a post-vaccine context.
    Newman PA; Duan N; Rudy ET; Johnston-Roberts K
    Vaccine; 2004 May; 22(15-16):1954-63. PubMed ID: 15121308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus infection/AIDS in children: the next decade.
    Ammann AJ
    Pediatrics; 1994 Jun; 93(6 Pt 1):930-5. PubMed ID: 8190579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.